WordNet

a form of interferon that is produced by fibroblasts and have antiviral effects; used in the treatment of multiple sclerosis
to remain unmolested, undisturbed, or uninterrupted -- used only in infinitive form; "let her be"
work in a specific place, with a specific subject, or in a specific function; "He is a herpetologist"; "She is our resident philosopher" (同)follow
have life, be alive; "Our great leader is no more"; "My grandfather lived until the end of war" (同)live
be identical to; be someone or something; "The president of the company is John Smith"; "This is my house"
happen, occur, take place; "I lost my wallet; this was during the visit to my parents house"; "There were two hundred people at his funeral"; "There was a lot of noise in the kitchen"
have the quality of being; (copula, used with an adjective or a predicate noun); "John is rich"; "This is not a good answer"
occupy a certain position or area; be somewhere; "Where is my umbrella?" "The toolshed is in the back"; "What is behind this behavior?"
spend or use time; "I may be an hour"
stake on the outcome of an issue; "I bet $100 on that new horse"; "She played all her money on the dark horse" (同)wager, play
the act of gambling; "he did it on a bet" (同)wager
maintain with or as if with a bet; "I bet she will be there!" (同)wager
second in order of importance; "the candidate, considered a beta male, was perceived to be unable to lead his party to victory"
the 2nd letter of the Greek alphabet
preliminary or testing stage of a software or hardware product; "a beta version"; "beta software"
the 9th letter of the Roman alphabet (同)i

PrepTutorEJDIC

《連結語として補語を伴なって…『である』,…だ,…です / 《位置・場所を表す語句を伴って》(…に)『ある』,いる(occupy a place or situation) / 〈物事が〉『存在する』,ある(exist);〈生物が〉生存する,生きている(live) / 行われる,起こる,発生する(take place, occur) / 存続する,そのままでいる(remain as before) / 《『be to』 do》 / …する予定である,…することになっている / …すべきだ / 《受動態の不定詞を伴って》…できる / 《命令》…するのだ / 《条件節に》…する意図がある / 《『if…were to』 do》…するとしたなら / 《『be』 do『ing』》《進行形》 / 《進行中の動作》…している,しつつある / 《近い未来》…しようとしている,するつもり / 《動作の反復》(いつも)…している / 《『be』+『他動詞の過去分詞』》《受動態》…される,されている / 《『be』+『自動詞の過去分詞』》《完了形》…した[状態にある]
『かけ』・(…との)かけ《+『with』+『名』》 / かけた物(金) / かけの対象 / 〈金・物〉'を'『かける』 / (かけ事・ゲームなどで)〈人〉‘と'『かけをする』《+『名』〈人〉+『on』+『名』》 / (…に)『かける』《+『on』(『against』)+『名』(one's do『ing』)》
ベータ(ギリシア語アルファベットの第2文字;B,β;英語のB,b に遭当)
『私は』私が
iodineの化学記号
intermediate frequency (無電の)中間周波

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における再発寛解型多発性硬化症の治療 treatment of relapsing remitting multiple sclerosis in adults
2. 炎症性ミオパチーの病因 pathogenesis of inflammatory myopathies
3. 成人における進行性多発性硬化症の治療 treatment of progressive multiple sclerosis in adults
4. 生物学的製剤を用いた癌治療の神経学的合併症 neurologic complications of cancer treatment with biologic agents
5. 切除可能な肝細胞癌のマネージメント：予後、術前補助化学療法と補助化学療法の役割、
および治療後サーベイランス management of potentially resectable hepatocellular carcinoma prognosis role of neoadjuvant and adjuvant therapy and posttreatment surveillance

English Journal

The NS1 protein of H5N6 feline influenza virus inhibits feline beta interferon response by preventing NF-κB and IRF3 activation.

Wang L1, Fu X2, Zheng Y1, Zhou P1, Fang B2, Huang S1, Zhang X1, Chen J3, Cao Z4, Tian J5, Li S6.
Developmental and comparative immunology.Dev Comp Immunol.2017 Sep;74:60-68. doi: 10.1016/j.dci.2017.04.003. Epub 2017 Apr 7.
PMID 28395999

The suppression of innate immune response by human rhinovirus C.

Pang LL1, Yuan XH2, Shao CS3, Li MZ4, Wang Y5, Wang HM5, Xie GC6, Xie ZP1, Yuan Y5, Zhou DM1, Sun XM1, Zhang Q1, Xin Y7, Li DD8, Duan ZJ9.
Biochemical and biophysical research communications.Biochem Biophys Res Commun.2017 Aug 12;490(1):22-28. doi: 10.1016/j.bbrc.2017.05.169. Epub 2017 May 31.
PMID 28576493

Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis.

Zettl UK1, Schreiber H2, Bauer-Steinhusen U3, Glaser T3, Hechenbichler K4, Hecker M1; BETAPATH Study Group.
Acta neurologica Scandinavica.Acta Neurol Scand.2017 Aug;136(2):116-121. doi: 10.1111/ane.12705. Epub 2016 Oct 30.
PMID 27796033

Japanese Journal

A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant